| Recovery Month |
Public Education Campaign |
SAMHSA |
NIDA |
The Substance Abuse and Mental Health Services Administration (SAMHSA) holds an annual public health observance for people in recovery from substance abuse. The National Institute on Drug Abuse (NIDA) is part of SAMHSA's inter-agency planning committee and a promotional partner. |
| Regenerative Medicine Innovation Project (RMIP) |
Committee, Work group, Advisory group, or Task Force |
FDA |
NIA, NIAMS |
NIAMS assumed the lead IC role in the Regenerative Medicine Innovation Project (RMIP) in 2023. The RMIP was established by the 21st Century Cures Act to accelerate progress in the field by supporting clinical research on adult stem cells, while promoting scientific rigor and protecting patient safety. This initiative is a trans-NIH effort, in coordination with the Food and Drug Administration (FDA). |
| Regenerative Medicine Innovation Project (RMIP) In-Depth Cell Characterization Hub (IDCCH) Scientific Oversight Subcommittee (SOS) |
Committee, Work group, Advisory group, or Task Force |
FDA, HRSA |
NCATS, NEI, NHLBI, NIA, NIAMS, NIDCD, NIDCR, NIDDK, NINDS |
The Regenerative Medicine Innovation Project was established by the 21st Century Cures Act to accelerate progress in the field by supporting clinical research on adult stem cells, while promoting scientific rigor and protecting patient safety. This initiative is a trans-NIH effort, in coordination with the Food and Drug Administration (FDA). |
| Regenerative Medicine Innovation Project (RMIP) Senior Oversight Committee |
Committee, Work group, Advisory group, or Task Force |
FDA, HRSA |
NCATS, NEI, NHLBI, NIA, NIAID, NIAMS, NIDCD, NIDCR, NIDDK, NINDS |
The Regenerative Medicine Innovation Project was established by the 21st Century Cures Act to accelerate progress in the field by supporting clinical research on adult stem cells, while promoting scientific rigor and protecting patient safety. This initiative is a trans-NIH effort, in coordination with the Food and Drug Administration (FDA). |
| Registry-based studies of hematologic malignancy incidence and survivorship |
Research Initiative |
FDA |
NCI |
NCI and FDA investigators are collaborating to utilize registry-based data to describe incidence trends of hematologic malignancies as well as second cancer risk and mortality patterns among hematologic malignancy survivors. |
| Research in Diabetes Mellitus, Its Complications, and Obesity |
Research Initiative |
IHS |
NIDDK |
The objectives are to identify the determinants and understand the progression of type 2 diabetes, obesity, and other chronic diseases in Native American and related populations. |
| Review Policy Committee (RPC) |
Committee, Work group, Advisory group, or Task Force |
AHRQ, CDC |
CSR, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/OER |
The Review Policy Committee (RPC) is the principal forum for the development, implementation, and evaluation of review policies and procedures for all types of research, training, and development awards submitted to the NIH. RPC membership includes one senior extramural review official from each NIH Institute and Center that has extramural review functions. The RPC has designated liaisons from other HHS agencies including Agency for Healthcare Research and Quality (AHRQ) and Centers for Disease Control and Prevention (CDC). From SLC: This description is still accurate. |
| Rheumatic and Autoimmune Diseases in Minority Communities |
Research Initiative |
FDA |
NHGRI |
This project studies the clinical presentation of rheumatic diseases in an underserved, largely ethnic minority community in the Washington, D.C. metropolitan area. Through the NIAMS Community Health Center, subjects with rheumatic complaints are evaluated and provide clinicians with first-hand experience in understanding ethnic differences in autoimmune disease phenotypes as well as barriers to care. https://reporter.nih.gov/search/TjYJobq_NUuCDBdx6gb8qA/project-details/… |
| Role of Gs-alpha in pancreatic islet cell growth and function |
Research Initiative |
FDA |
NIDDK |
Role of Gs-alpha in pancreatic islet cell growth and function |
| Rural Opioid Initiative |
Research Initiative |
AHRQ, CDC, SAMHSA |
NIDA |
The ROI consists of eight research teams centrally located in rural areas whose overarching aim is to help communities develop comprehensive approaches to prevent and treat outcomes related to substance use. |